Ayahuasca Therapy Guide: What to Know Before You Go
This ayahuasca therapy guide covers what you need to know before considering a ceremony or retreat: how it works pharmacologically, what the safety risks actually are,...
Psychedelic Therapy Privacy: What Executives Need to Know
Psychedelic therapy privacy is one of the most legitimate concerns executives and public figures raise before pursuing treatment. HIPAA protections apply to licensed clinical providers, and...
Set and Setting in 2026: A Psychedelic Preparation Guide for High-Performers
Set and setting psychedelics research refers to the two core non-pharmacological factors that shape a psilocybin experience: your internal state (set) and the physical and relational...
Why Choosing the Right Psychedelic Guide Matters More Than You Think?
Quick answer: The right psychedelic guide is someone who combines safety awareness, strong boundaries, real preparation, and integration support with a communication style and presence that...
MDMA Therapy FDA Decision, What the Rejection Letter Means for Seekers
The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time,...
Ketamine Therapy Preparation: What to Expect and Why It Matters
Ketamine therapy preparation is not a formality you complete before the real thing begins. It is a functional part of what makes the treatment work. What...
AI Digital Tripsitter: What It Can and Cannot Do for You
An AI digital tripsitter is a software tool, usually an app or chatbot, designed to support psychedelic experiences through journaling prompts, intention-setting, and guided reflection. These...
Healing Together: Psychedelic Therapy, Partnership, and the Power of Personalized Guidance
Psychedelic guide matching is one of the most important decisions a seeker can make, and at JourneyOM, it is never left to an algorithm. This post...
RFK Jr. and Psychedelic Therapy: What Seekers Should Know
RFK Jr. psychedelic therapy support has brought real political attention to substances like psilocybin, MDMA, and ibogaine. For seekers already exploring this space, the shift matters....
Psychedelic Nasal Spray for Depression: What the Research Shows
A psychedelic nasal spray for depression called BPL-003 has produced rapid, meaningful antidepressant effects in clinical trials, earning FDA Breakthrough Therapy designation in late 2025. The...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.